Results 281 to 290 of about 282,997 (350)

Molecular insights into pangenome localization and constructs design for Hemophilus influenza vaccine. [PDF]

Sci Rep
Zaman N, Gul K, Khurram K, Azam SS.
europepmc   +1 more source

Nicotiana benthamiana's Responses to Agroinfiltration, a Treasure Grove of New Avenues to Improve Protein Yields in Plant Molecular Farming

Plant Biotechnology Journal, EarlyView.
ABSTRACT Transient expression of recombinant proteins in leaves of Nicotiana benthamiana is routinely employed for both basic research and manufacturing of biopharmaceutical products in plants. Relying on disarmed strains of the bacterial plant pathogen Agrobacterium tumefaciens as a transgene vector, this safe, cost‐effective and easily scalable ...
Louis‐Philippe Hamel
wiley   +1 more source

Intranasal Mosaic H1N1 Live Attenuated Influenza Vaccine Elicits Broad Cross-Reactive Immunity and Protection Against Group 1 and 2 Influenza A Viruses. [PDF]

MedComm (2020)
Ma X, Chen Q, Cai Y, Chen C, Lu J, Yang Z, Han X, Wang L, Liu X, Shi Y, Zhang Y, Xin L, Chen Y, Ma R, Pang W, Bai T, Shu Y.   +16 more
europepmc   +1 more source

Influenza Virus: Global Health Impact, Strategies, Challenges, Role of Nanotechnolgy in Influenza Vaccine Development. [PDF]

Vaccines (Basel)
Parvez S, Pathrathota A, Uppar AL, Yadagiri G, Mudavath SL.   +4 more
europepmc   +1 more source

Mucosal boosting increases protective efficacy of an influenza vaccine in mice. [PDF]

iScience
Wang L, Chan CN, Chaudhari J, Hope D, Espinosa Perez AA, Lasrado N, Li Z, Waller-Pulido A, Cabrera-Barragan DN, Verrette B, Nangle SJ, Ayala-Bernot J, Jacob-Dolan C, Lifton M, Strutton E, Fisher J, Mbiwan E, Rossler A, Schrag S, Barouch DH.   +19 more
europepmc   +1 more source

Self-perceptions of aging mediate the association between illness perception and influenza vaccine hesitancy in older adults with pneumonia during the 2024-2025 influenza season. [PDF]

Front Public Health
Liu J, Wang Y, Zhu Z, Li J, Wang Y, Xu S.   +5 more
europepmc   +1 more source

Live attenuated influenza vaccine with low proportions of defective interfering particles elicits robust immunogenicity and cross-protection. [PDF]

Nat Commun
Wu M, Wang P, Wang L, Li C, Sheng R, Dong H, Fu X, Zhou E, Zhang C, Lu T, Jin Z, Qin J, Miao Y, Yue L, Pan D, Li C, Liang C, Kiseleva I, Rudenko L, Jiang C, Chen F, Su W.   +21 more
europepmc   +1 more source